Evenity Unione Europea - italiano - EMA (European Medicines Agency)

evenity

ucb pharma s.a. - romosozumab - osteoporosi - farmaci per il trattamento delle malattie ossee - evenity è indicato nel trattamento della grave osteoporosi nelle donne in postmenopausa ad alto rischio di frattura.

Xyrem Unione Europea - italiano - EMA (European Medicines Agency)

xyrem

ucb pharma ltd - sodio oxibato - cataplexy; narcolepsy - altri farmaci sul sistema nervoso - trattamento della narcolessia con cataplessia in pazienti adulti.

Bimzelx Unione Europea - italiano - EMA (European Medicines Agency)

bimzelx

ucb pharma s.a.   - bimekizumab - psoriasi - immunosoppressori - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.

Zyrtec Plus Retardtabletten Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

zyrtec plus retardtabletten

ucb-pharma sa - cetirizini dihydrochloridum, pseudoephedrini hydrochloridum - retardtabletten - cetirizini dihydrochloridum 5 mg, pseudoephedrini hydrochloridum 120 mg, hypromellosum, lactosum monohydricum 43.23 mg, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium 0.122 mg, pellicule: hypromellosum, e 171, macrogolum 400, pro compresso obducto. - rinite allergica - synthetika

NARISTAR Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

naristar

ucb pharma s.p.a. - pseudoefedrina, associazioni - pseudoefedrina, associazioni

NIFEREX Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

niferex

ucb pharma s.p.a. - ferro (ii) glicina solfato - ferro (ii) glicina solfato